Patriot Financial Group Insurance Agency LLC increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 118.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,548 shares of the medical device company’s stock after buying an additional 9,502 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s holdings in Cooper Companies were worth $1,255,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in COO. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after purchasing an additional 158 shares in the last quarter. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the period. Allworth Financial LP raised its stake in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares in the last quarter. Blue Trust Inc. raised its stake in Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares in the last quarter. Finally, Norden Group LLC lifted its position in Cooper Companies by 3.2% during the fourth quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock worth $544,000 after purchasing an additional 205 shares during the period. Institutional investors own 24.39% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on COO shares. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research note on Wednesday, May 27th. Barclays upped their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. Needham & Company LLC decreased their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Finally, Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $81.31.
Cooper Companies Stock Up 0.5%
COO stock opened at $71.39 on Tuesday. The stock has a market capitalization of $13.92 billion, a P/E ratio of 60.50, a price-to-earnings-growth ratio of 1.86 and a beta of 0.88. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The firm has a 50-day moving average price of $64.14 and a 200-day moving average price of $73.56.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Read More
- Five stocks we like better than Cooper Companies
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
